# Advanced Biohealing

**Canonical:** https://apis.io/providers/advanced-biohealing/  
**APIs profiled:** 0

Advanced BioHealing, Inc. was a regenerative medicine company best known for Dermagraft, a cryopreserved human fibroblast-derived dermal substitute used to treat diabetic foot ulcers. The company acquired the Dermagraft assets from Smith & Nephew in 2006, was backed by Canaan Partners and other venture investors, and was acquired by Shire plc for $750 million in cash in June 2011 to seed Shire's regenerative medicine business unit. Dermagraft was later sold to Organogenesis in 2014. Advanced BioHealing no longer operates as an independent entity and publishes no public developer portal, API, or programmatic surface; this profile is retained in the API Evangelist network as a venture-portfolio company record.

## Kin Score — 2.2 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 2.2).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 0.0 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Tags

Company, Regenerative Medicine, Biotechnology, Medical Devices, Healthcare, Wound Care, Life Sciences, Venture Portfolio

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/advanced-biohealing/). Scores are computed from the provider's own public artifacts under a published rubric.